RxDoctor Payments Data

Kevin Yaryan

Optometrist · Connersville, INNPI 1508027269

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (46.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Alcon accounts for 78.3% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $2,899 and has fallen 86.0% since, to $407 in 2025. Among optometrist clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,892in general payments, 2019–2025

Across 82 payments — averaging $71.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$5K
  • Coopervision Inc.$545
  • Bausch & Lomb Americas Inc.$204
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$112
  • Optos, Inc.$105
  • AbbVie$101
  • plus $213 from 6 others

What the payments were for

  • Consulting fees$95016%
  • Travel & lodging$2,08335%
  • Food & beverage$2,75447%
  • Entertainment$1052%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,892 in reported general payments places this provider in the 95th percentile of 1,318 optometrist providers in Indiana.

See all optometrist providers in Indiana

Medicare billing

Part B allowed, 2024
$65,551
Medicare patients
415
Services billed
707

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LumiganBimatoprost78$37,569
XiidraLifitegrast25$33,801
RestasisCyclosporine25$27,425
Cyclosporine11$3,741
Alphagan PBrimonidine Tartrate15$3,562
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol21$3,274
Loteprednol Etabonate19$3,106
Travoprost22$2,898
Prednisolone Acetate52$1,928
Latanoprost172$1,473
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat43$806
Brimonidine Tartrate43$672
Dorzolamide Hcl39$656
Timolol Maleate55$394
Acyclovir25$237

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLumigan, Restasis, Alphagan P$101$68,555118 claims
Bausch & Lomb Americas Inc.Xiidra$204$33,80125 claims
Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate$112$3,10619 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,318 optometrist providers in Indiana.

Other optometrist in Connersville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →